Key Milestones

Picture

- Became the first Bangladeshi pharmaceutical company to commence export of pharmaceutical products to the USA.
- Received approvals for two ANDAs (Sotalol tablets and Metformin ER tablets) from the US Food and Drug Administration (U.S. FDA)
- Formed the Company’s first overseas manufacturing collaboration with the joint venture with BioCare Manufacturing (M) Sdn Bhd based in Malaysia.
- Granted a sub-license by Medicine Patent Pool of the UN to produce Bristol-Myers Squibb’s new hepatitis C drug Daclatasvir.

2016-17
Movie

- Received GMP approval from the U.S. FDA as the first Bangladeshi company
- Launched generic version of revolutionary hepatitis C drugs Sovaldi® and Harvoni®
- Received product approval from Health Canada as the first Bangladeshi company
- Entered the Gulf pharma market (Kuwait) as the first Bangladeshi company
- Won National Export Trophy (Gold) for the record 5th time

2015-16
Picture

- Received GMP accreditation from Taiwan Food & Drug Administration (TFDA) and Health Canada as the first Bangladeshi company
- Exported medicine to Australia and Romania as the first Bangladeshi company

2014
Picture

- Commenced export of ophthalmic products to Europe as the first Bangladeshi company

2013
Movie

- Launched Salbutamol HFA inhaler (Azmasol®) in Singapore as the first Bangladeshi company

2012
Picture

- Received GMP accreditation from AGES, Austria (for European Union)

2011
Location

- Entered into the US market through acquisition of an Abbreviated New Drug Application (ANDA) as the only pharmaceutical company in Bangladesh

2010
Location

- Received GMP approval from ANVISA, Brazil as the first Bangladeshi company

2009
Movie

- Received GMP accreditation from Therapeutic Goods Administration (TGA), Australia and Gulf Central Committee for Drug Registration, for GCC states as the first Bangladeshi company
- Entered into technology transfer arrangement to manufacture Roche’s ARV drug Saquinavir

2008
Location

- Launched CFC free HFA inhalers for the first time in Bangladesh

2006
Location

- Only company in Bangladesh to get listed on the Alternative Investment Market (AIM) of London Stock Exchange (LSE) through issuance of GDRs

2005
Location

- Introduced anti-retroviral (ARV) drugs as the first Bangladeshi company

2003
Location

- Russia became the first export destination for formulation products

1993
Location

- Started export operations with APIs

1992
Location

- Listed on Dhaka Stock Exchange

1985
Location

- Launched own formulation brands

1983
Location

- Started manufacturing products of Bayer AG, Germany and Upjohn Inc., USA, under license agreements

1980
Location

- Company incorporated

1976